Viewing Study NCT06494150


Ignite Creation Date: 2025-12-24 @ 5:20 PM
Ignite Modification Date: 2025-12-26 @ 2:38 PM
Study NCT ID: NCT06494150
Status: RECRUITING
Last Update Posted: 2025-01-16
First Post: 2024-07-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)
Sponsor: University of Oklahoma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module